Drug Shortage Report for JAMP-RISPERIDONE
| Report ID | 207292 |
| Drug Identification Number | 02454319 |
| Brand name | JAMP-RISPERIDONE |
| Common or Proper name | Risperidone |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | DORMANT |
| Active Ingredient(s) | RISPERIDONE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | 30 mL |
| ATC code | N05AX |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-10-16 |
| Estimated end date | 2025-12-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-12-03 |
| Company comments | Increase in demand / Allocations |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2024-12-03 | French | Compare |
| v9 | 2024-12-03 | English | Compare |
| v8 | 2024-10-31 | French | Compare |
| v7 | 2024-10-31 | English | Compare |
| v6 | 2024-07-03 | French | Compare |
| v5 | 2024-07-03 | English | Compare |
| v4 | 2023-11-15 | French | Compare |
| v3 | 2023-11-15 | English | Compare |
| v2 | 2023-10-18 | French | Compare |
| v1 | 2023-10-18 | English | Compare |
Showing 1 to 10 of 10